BiondVax Pharmaceuticals Ltd.
BVXVW
BVXVW was delisted on the 13th of May, 2020.
3 hedge funds and large institutions have $60K invested in BiondVax Pharmaceuticals Ltd. in 2019 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
12% less capital invested
Capital invested by funds: $68K → $60K (-$8K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.21K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CH
1
CVI Holdings
Wilmington,
Delaware
| $45K | – | – | – |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $14K | +$2.21K | +2,252 | +11% |
|
3
UBS Group
Zurich,
Switzerland
| $1K | – | – | – |
|
BVXVW Hedge Fund Activity: Q3 2019 in Review
3 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in BiondVax Pharmaceuticals Ltd. (BVXVW) for Q3 2019, worth a combined $60K — down 12% from $68K a quarter earlier.
Fund positioning in BVXVW was balanced in Q3 2019: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $2.21K.
- 3 institutional investors held BiondVax Pharmaceuticals Ltd. (BVXVW) as of Q3 2019, unchanged from Q2 2019.
- Funds reported $60K of BiondVax Pharmaceuticals Ltd. stock for Q3 2019, down 12% quarter-over-quarter.
- 0 funds opened new BiondVax Pharmaceuticals Ltd. positions in Q3 2019 and 0 closed out.
- The largest BiondVax Pharmaceuticals Ltd. buyer in Q3 2019 was Susquehanna International Group, an estimated $2.21K added.
Based on aggregated 13F filings for Q3 2019.